Search icon

APOVAX, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: APOVAX, INC.
Legal type: Foreign Corporation
Status: Inactive
Standing: Good
Profit or Non-Profit: Profit
File Date: 15 Aug 2001 (24 years ago)
Authority Date: 15 Aug 2001 (24 years ago)
Last Annual Report: 07 Jul 2014 (11 years ago)
Organization Number: 0520961
ZIP code: 40204
City: Louisville
Primary County: Jefferson County
Principal Office: 1044 E. CHESTNUT STREET, LOUISVILLE, KY 40204
Place of Formation: DELAWARE

Chairman

Name Role
Steve Gailar Chairman

Executive

Name Role
Haval Shirwan Executive

Director

Name Role
Haval Shirwan Director
Steve Gailar Director

Registered Agent

Name Role
KY SECRETARY OF STATE Registered Agent

Form 5500 Series

Employer Identification Number (EIN):
611392013
Plan Year:
2010
Number Of Participants:
14
Sponsors Telephone Number:
Plan Year:
2009
Number Of Participants:
9
Sponsors Telephone Number:

Former Company Names

Name Action
APOIMMUNE INC. Old Name

Filings

Name File Date
App. for Certificate of Withdrawal 2014-07-09
Annual Report 2014-07-07
Principal Office Address Change 2013-05-31
Annual Report 2013-05-31
Annual Report 2012-06-08

USAspending Awards / Contracts

Procurement Instrument Identifier:
HSHQDC13C00018
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Action Obligation:
194740.00
Base And Exercised Options Value:
194740.00
Base And All Options Value:
516810.00
Awarding Agency Name:
Department of Homeland Security
Performance Start Date:
2013-02-21
Description:
IGF::OT::IGF THE PURPOSE OF THIS CONTRACT IS TO PROVIDE FUNDING FOR THE DEVELOPMENT OF A NOVEL VACCINE FOR FOOT-AND-MOUTH DISEASE (FMD).
Naics Code:
541711: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Product Or Service Code:
AJ52: R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Procurement Instrument Identifier:
HSHQDC11C00136
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Action Obligation:
431115.00
Base And Exercised Options Value:
644736.20
Base And All Options Value:
1083743.08
Awarding Agency Name:
Department of Homeland Security
Performance Start Date:
2011-09-29
Description:
DIVISION: CHEMICAL&BIOLOGICAL PPA: CHEMICAL&BIOLOGICAL THRUST: AGRICULTURE PROGRAM: AG DEFENSE BASIC RESEARCH PROJECT: FAD VACCINES&DIAGNOSTICS PERFORMER: APOIMMUNE, INC. APPROPRIATION YEAR: FY11 (13 FUNDS) BUDGET AUTHORITY: THREE-YEAR R&D FUNDS PROJECT MANAGER: BRUCE HARPER LEAD SUPPORT STAFF: ROBERT ORR, 202-254-6606 ALC: 70-08-1513 APPS: 70130800 DESCRIPTION: THE PURPOSE OF THIS REQUISITION IS TO PROVIDE FUNDING FOR PHASE 1 OF THE APOVAX104 AS A NOVEL VACCINE FOR FOOT AND MOUTH DISEASE FOR $431,115 TO APOIMMUNE, INC. AS THEY ARE A SELECTED PERFORMER UNDER LRBAA 10-01-F054.
Naics Code:
541711: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Product Or Service Code:
AJ52: LIFE SCIENCES (APPLIED/EXPLORATORY)

USAspending Awards / Financial Assistance

Date:
2010-09-03
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
APOFASL AS A NOVEL TREATMENT FOR TYPE 1 DIABETES IN NONHUMAN PRIMATES
Obligated Amount:
850924.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2008-08-27
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
APOVAX104-TB AS A NOVEL VACCINE FOR TUBERCULOSIS
Obligated Amount:
821483.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2008-07-30
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
APOVAX104-HPV AS A NOVEL VACCINE FOR CERVICAL CANCER
Obligated Amount:
1771799.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks

Serial Number:
78867521
Mark:
PROTEX
Status:
Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Service Mark
Application Filing Date:
2006-04-23
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
PROTEX

Goods And Services

For:
Method for design and engineering of recombinant chimeric proteins and attachment of those proteins to a desired target, which may be biological or synthetic in nature, for diagnostic or therapeutic purposes
First Use:
2003-09-15
International Classes:
042 - Primary Class
Class Status:
ACTIVE

Reviews Leave a review

This company hasn't received any reviews.

Financial Incentive

Program Program Status Average Hourly Wage Project Cost Incentive Amount Initial Jobs New Jobs Date of Action Approval Type
SBIR/STTR Inactive - $0 $430,000 - - 2010-01-01 Final
SBIR/STTR Inactive - $0 $100,000 - - 2008-11-01 Final
SBIR/STTR Inactive - $0 $500,000 - - 2008-10-01 Final
SBIR/STTR Inactive - $0 $100,000 - - 2007-10-01 Final
SBIR/STTR Inactive - $0 $100,000 - - 2007-03-01 Final

Sources: Kentucky Secretary of State